Status: Recruiting
Brexanolone Lifting Outcomes Of Moms
The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause
Participants needed: 120
Trial details
Phase: Phase 3Age: 15-45Biological sex: FemaleType: InterventionalSponsor: Lipocine Inc.Updated: Sep 16, 2026Locations: 16
Eligibility criteria
Are female between 15 and 45 years of age, inclusive; [+3]
Have a history of bipolar disorder, schizophrenia or schizoaffective disorder [+3]